2022-502420-51-00已完成4 期
An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavailability of Dimenhydrinate 50 mg (Test) administered with and without water vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Reference 1) and Biodramina 50 mg Comprimidos (Reference 2)
CCDRD Cooperative Clinical Drug Research and Development AG, Hermes Pharma GmbH1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2023年10月2日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Sacha Arsova; MD, PhD
Scientific
CCDRD Cooperative Clinical Drug Research and Development AG
研究点 (1)
Loading locations...
相似试验
已完成
Unknown
A Study to Evaluate the Safety and Bioequivalence of AD-201 Compared to Coadministration of AD-2011 and AD-2012Diseases of the circulatory systemKCT0009387Addpharma58
已完成
1 期
An open label, single cohort, randomized, 4-period crossover Phase 1 study to determine the effect of meal timing relative to CRN00808 administration on the safety and pharmacokinetics of CRN00808 in healthy volunteersMetabolic and Endocrine - Other endocrine disordersAcromegalyACTRN12618001646235Crinetics Australia Pty Ltd12
招募中
1 期
A clinical trial to study the effect of SMC021 on the blood levels of ibuprofen and paracetamol and the effect of ibuprofen and paracetamol in blood levels of SMC021CTRI/2009/091/001052ovartis Healthcare Pvt Ltd56
尚未招募
不适用
To assess the bioavailability, safety, and efficacy of Resveratrol and Pterostilbene in NOVAGENERE XAR and NOVAGENERE XAPCTRI/2022/07/044061Epigeneres Biotech Pvt Ltd
已完成
4 期
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Valacyclovir Oral Suspension compared to Valtrex® Tablets in normal, healthy subjects under fasting conditions.2024-511570-77-00Dermax30